Navigation Links
Sermo Study shows 70% of Specialists are Ready to Replace Warfarin
Date:12/3/2010

CAMBRIDGE, Mass., Dec. 3, 2010 /PRNewswire/ -- Sermo (http://www.sermo.com), the world's largest online community for physicians, today announced a free Sermo Report titled, "Potential Replacements for Coumadin (warfarin)." The report gathered feedback from physicians about awareness and understanding of these products and potential barriers to prescribing.

65% of all respondents were aware that a new product, Pradaxa (dabigatran etexilate mesylate), was currently available for use. Others indicated that while they may use Pradaxa, they are awaiting the approval of a similar drug, Xarelto (rivaroxaban).

This free Sermo Report polled 141 physicians across multiple specialties. Respondents discussed the importance of understanding how to reverse the effects of these medications when necessary, drug-drug interactions and dosing.  

Physicians shared their points of view on the advantages of replacing warfarin:

"...I think that this will be a watershed event in the treatment of non-valvular AF, and hopefully in other conditions, such as VTE, requiring anti-coagulation.  I hope that soon Coumadin will only be found in history books"  

-Family Medicine

"Dosing up to twice a day compared to once a day for warfarin could be acceptable since dabigatran needs no monitoring. Still QD dosing improves compliance."

-Internal Medicine

Many of the respondents also participated in an online discussion regarding various treatment strategies and shared their plans to use the newly available therapy.

The full report includes:

  • Key Findings
  • Physician Demographics
  • Discussion Highlights
  • Quantitative and Qualitative Post Analysis

Companies that are in t
'/>"/>

SOURCE Sermo
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sermo Report Indicates that Ticagrelor is Likely to Affect the Standard of Care for ACS Patients
2. Sermo Study Shows 63% of Physicians Would Utilize New Gout Treatments
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
10. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Belgium , Sept. 1, 2015 ... company focused on developing blood-based diagnostic tests for a broad ... its Chief Executive Officer, Cameron Reynolds , is scheduled ... Conference, which is being held September 9-10, 2015 in ... all day on September 10. Wells Fargo ...
(Date:9/1/2015)... BAKERSFIELD, Calif. , Sept. 1, 2015 /PRNewswire/ ... Chronic Care Management (CCM) and Drug Adherence m ... monitoring help automate the process of non face-to-face ... "With this new release of our apps, ... care management services along with our ONCHIT certified ...
(Date:9/1/2015)... , Sept. 1, 2015   Ivenix Inc. ... infusion management system, closed on a $42M round ... Healthcare Ventures. Cardinal Partners, CICA, Inc., Easterly Capital, ... in the round. This financing will support the ... market. Leerink Partners LLC acted as the exclusive ...
Breaking Medicine Technology:VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 2VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 3VolitionRx to Attend 10th Annual Wells Fargo Healthcare Conference on September 9-10, 2015 4SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3
... CHICAGO, June 3, 2011 Cornerstone Pharmaceuticals ... findings from a Phase I clinical trial of Cornerstone,s ... Leukemia (AML). Data will be presented at the 47th ... http://www.chicago2011.asco.org/ . Cornerstone is a leader in the ...
... June 3, 2011 DURECT Corporation (Nasdaq: DRRX ... be presenting at the Jefferies Healthcare Conference on Tuesday, June ... held at the Grand Hyatt in New York.   ... webcast of the presentation will be available by accessing DURECT,s ...
Cached Medicine Technology:Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia 2Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia 3Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia 4
(Date:9/1/2015)... Vegas, NV (PRWEB) , ... September 01, 2015 ... ... care or Self-Directed Care is, how to access caregivers and what to look ... other valuable and pertinent information. , Founded in 2006 in Canoga Park, CA ...
(Date:9/1/2015)... ... 01, 2015 , ... The integration of Practice Perfect and ... Perfect to FOTO enabling cost and time savings, reducing errors and omissions, and ... of Practice Perfect, stated "FOTO is a natural extension of Practice Perfect, ...
(Date:9/1/2015)... ... ... Routines… every family has them. Whether it’s a morning routine, meal time routine ... children too. Here are three reasons why routines can be beneficial for a child: ... routine is implemented into a child’s schedule, they are able to anticipate what will ...
(Date:9/1/2015)... ... ... Specialty Technical Publishers (STP) and Specialty Technical Consultants (STC) ... audit protocol for the European Union. Leading companies around the world use IAPC ... rapidly collect, share, archive, and export audit findings in a cost-effective manner. , ...
(Date:8/31/2015)... ... September 01, 2015 , ... The PT Outcomes Registry is an organized system ... therapy patients. The Registry is being developed by the American Physical Therapy Association (APTA). ... to be selected to contribute FOTO Outcomes measures as one of the primary global ...
Breaking Medicine News(10 mins):Health News:AdvantagePlusCaregivers.com® Launches New Website for Corporate and Franchisee Locations in 3 States 2Health News:FOTO Announces New Integration Partnership with Practice Perfect 2Health News:Back into the Swing of Things: How Family Routines Benefit Children 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 4Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2
... SOPHIA ANTIPOLIS, France, May 6 NicOx S.A.,(Euronext ... U.S. phase 2 study,conducted by its partner Pfizer ... doses of PF-03187207 to Xalatan(R) (latanoprost) 0.005% in,patients ... doses of PF-03187207 demonstrated a clinically significant reduction,in ...
... 1st May 2008: Some of the UKs leading experts ... as RFID in hospitals are already improving the efficiency ... that compatibility problems between hardware and software applications, and ... mean that the NHS is not benefiting as much ...
... Researchers have discovered how a mole develops into melanoma ... in 60-70 percent of tumors. The Penn State ... is necessary for drugs to effectively treat this deadly ... two proteins (V600E)B-Raf and Akt3 communicate with ...
... N.Y., May 6 VirtualCDO acted as the ... of the company to Lawson,Software (St. Paul, MN). ... services, assisted healthcare, hospitality and government,service companies in ... enterprise management services to some 4,000 customers across,40 ...
... - DRAXIS Health Inc. (TSX: DAX),(Nasdaq: DRAX ) ... 2008 on Friday May 9, 2008., Annual and ... meeting (the "Meeting") of shareholders of,DRAXIS is scheduled to ... 5300, TD Bank Tower, Toronto, Ontario, Canada on Friday, ...
... Patients, Safety,Concerns, But Lack Confidence About Best Ways ... As patient safety,incidents in America,s hospitals continue ... hospital CEOs feel strongly confident about practices in,place ... the VHA Foundation,today formally launched the "Health Care ...
Cached Medicine News:Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 2Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 3Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 4Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 5Health News:NicOx Announces U.S. Phase 2a Results for PF-03187207 and Gives an Update on Continuing NO-prostaglandin Program 6Health News:Location! Location! Location technologies are improving NHS care 2Health News:Scientists identify interacting proteins key to melanoma development, treatment 2Health News:Scientists identify interacting proteins key to melanoma development, treatment 3Health News:VirtualCDO Acts as M&A Advisor in Sale of VasTech to Lawson Software 2Health News:DRAXIS to Report First Quarter Results on May 9th 2Health News:DRAXIS to Report First Quarter Results on May 9th 3Health News:DRAXIS to Report First Quarter Results on May 9th 4Health News:VHA Foundation Launches National CEO Patient SafetyNetwork, Starting From the Top to Make Patients Safer 2Health News:VHA Foundation Launches National CEO Patient SafetyNetwork, Starting From the Top to Make Patients Safer 3
Titanium hemi arthroplasty implant for degenerative and post-traumatic arthritis of first metatarsophalangeal joint....
... Cranial Nerve Electrodes provide direct cranial ... Their patented circumferential design provides sensitive ... high-quality, stable real-time recordings. This unique ... during the removal of acoustic neuromas, ...
... of Ad-Techs products, our Sphenoidal Electrodes are manufactured ... available in stainless steel or platinum and feature ... (70 mm) long, 21 gauge (0.83 mm) introducing ... as kits or sets. You can also choose ...
... Stellate Harmonie workstation is a medical device ... high quality video capability, and archiving demands ... review functions A framework that helps organize ... of data A centralized database and powerful ...
Medicine Products: